References
- Germain DP. Fabry disease. Orphanet J Rare Dis 2010;5:30. https://doi.org/10.1186/1750-1172-5-30
- Muller-Hocker J, Schmid H, Weiss M, Dendorfer U, Braun GS. Chloroquine-induced phospholipidosis of the kidney mimicking Fabry's disease: case report and review of the literature. Hum Pathol 2003;34:285-89. https://doi.org/10.1053/hupa.2003.36
- von Scheidt W, Eng CM, Fitzmaurice TF, Erdmann E, Hubner G, Olsen EG, Christomanou H, Kandolf R, Bishop DF, Desnick RJ. .An atypical variant of Fabry's disease with manifestations confined to the myocardium. N Engl J Med 1991;324:395-99. https://doi.org/10.1056/NEJM199102073240607
- Ko YH, Kim HJ, Roh YS, Park CK, Kwon CK, Park MH. Atypical Fabry's disease.An oligosymptomatic variant. Arch Pathol Lab Med 1996;120:86-9.
- Germain DP.General aspects of X-linked diseases. In: Mehta A, Beck M, Sunder-Plassmann G, editors. Fabry Disease: Perspectives from 5 years of FOS. Oxford, UK: Oxford PharmaGenesis, 2006.
- Germain DP. Genetics of Fabry disease: diagnostic and therapeutic implications. Presse Med 2007;36 Spec No 1:1S14-19. https://doi.org/10.1016/j.lpm.2006.12.018
- Banks DE, Milutinovic J, Desnick RJ, Grabowski GA, Lapp NL, Boehlecke BA. Silicon nephropathy mimicking Fabry's disease. Am J Nephrol 1983;3:279-84. https://doi.org/10.1159/000166730
- Albay D, Adler SG, Philipose J, Calescibetta CC, Romansky SG, Cohen AH. Chloroquine-induced lipidosis mimicking Fabry disease. Mod Pathol 2005;18:733-38. https://doi.org/10.1038/modpathol.3800344
- Bracamonte ER, Kowalewska J, Starr J, Gitomer J, Alpers CE. Iatrogenic phospholipidosis mimicking Fabry disease. Am J Kidney Dis 2006;48:844-50. https://doi.org/10.1053/j.ajkd.2006.05.034
- Sessa A, Meroni M, Battini G, Maglio A, Brambilla PL, Bertella M, Nebuloni M, Pallotti F, Giordano F, Bertagnolio B, et al. Renal pathological changes in Fabry disease. J Inherit Metab Dis 2001;24 Suppl 2:66-70; discussion 65. https://doi.org/10.1023/A:1012423924648
- Faraggiana T, Churg J, Grishman E, Strauss L, Prado A, Bishop DF, Schuchman E, Desnick RJ. Light- and electron-microscopic histochemistry of Fabry's disease. Am J Pathol 1981;103:247-62.
- Alroy J, Sabnis S, Kopp JB. Renal pathology in Fabry disease. J Am Soc Nephrol 2002;13 Suppl 2:S134-38. https://doi.org/10.1097/01.ASN.0000016684.07368.75
- Scheurle C, Dammrich M, Becker JU, Baumgartel MW. Renal phospholipidosis possibly induced by ranolazine. Clin Kidney J 2014;7:62-4. https://doi.org/10.1093/ckj/sft141
- Reasor MJ, Hastings KL, Ulrich RG. Drug-induced phospholipidosis: issues and future directions. Expert Opin Drug Saf 2006;5:567-83. https://doi.org/10.1517/14740338.5.4.567
- Hruban Z, Slesers A, Hopkins E. Drug-induced and naturally occurring myeloid bodies. Lab Invest 1972;27:62-70.
- de Duve C, de Barsy T, Poole B, Trouet A, Tulkens P, Van Hoof F. Commentary. Lysosomotropic agents. BiochemPharmacol 1974;23:2495-531.
- Homewood CA, Warhurst DC, Peters W, Baggaley VC. Lysosomes, pH and the anti-malarial action of chloroquine. Nature 1972;235:50-2. https://doi.org/10.1038/235050a0